EJNMMI Reports

Table 1 Distribution of studies per patient, including [¹⁸F]FDG and [¹⁸F]FLT scans, at baseline, interim and end-of-treatment stages

From: Exploring the applicability of a lesion segmentation method on [¹⁸F]fluorothymidine PET/CT images in diffuse large B-cell lymphoma

Patient ID	Baseline		Interim		End-of-treatment
Patient ID	FDG	FLT	FDG	FLT	FDG	FLT
1	×	−	×	×	×	×
2	×	×	−	−	−	−
3	×	×	−	×	−	−
4	×	×	×*	×*	×	×
5	×	−	−	×	×	×
6	×	×	×	−	×	−
7	×	×*	×*	−	−	×*
8	×	×	×	×	−	×
9	×	×	×	×	−	−
10	×	×	−	×	×*	×
11	×	×	−	×	×*	×*
12	×	×	×	×	×	×
13	−	−	×*	×*	×	−
14	×	×	×*	×*	×*	×*
15	×	×	×	×	×	×
16	−	×	×	×	−	−
17	×	×*	−	−	−	−
18	×	−	×	×	−	−
19	×	−	−	×*	×*	× *
20	×	×	−	−	−	−
21	×	×	−	−	−	−
22	×	×	−	×*	×	×
23	×	×	×	×	−	−
Number of scans:	21	18	13	17	12	12

×: Scan performed and segmented
×*: Scan performed without abnormal uptake (no lesions to segment)
−: Scan not performed

Back to article page